Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Ann Rheum Dis ; 73(1): 284-9, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23511227

RESUMO

BACKGROUND: Alkaptonuria (AKU) is a rare metabolic disease caused by deficiency of homogentisate 1,2 dioxygenase, an enzyme involved in tyrosine catabolism, resulting in increased circulating homogentisic acid (HGA). Over time HGA is progressively deposited as a polymer (termed ochronotic pigment) in collagenous tissues, especially the cartilages of weight bearing joints, leading to severe joint disease. OBJECTIVES: To characterise blood biochemistry and arthropathy in the AKU mouse model (Hgd-/-). To examine the therapeutic effect of long-term treatment with nitisinone, a potent inhibitor of the enzyme that produces HGA. METHODS: Lifetime levels of plasma HGA from AKU mice were measured by high-performance liquid chromatography (HPLC). Histological sections of the knee joint were examined for pigmentation. The effect of nitisinone treatment in both tissues was examined. RESULTS: Mean (±SE) plasma HGA levels were 3- to 4-fold higher (0.148±0.019 mM) than those recorded in human AKU. Chondrocyte pigmentation within the articular cartilage was first observed at 15 weeks, and found to increase steadily with mouse age. Nitisinone treatment reduced plasma HGA in AKU mice throughout their lifetime, and completely prevented pigment deposition. CONCLUSIONS: The AKU mouse was established as a model of both the plasma biochemistry of AKU and its associated arthropathy. Early-stage treatment of AKU patients with nitisinone could prevent the development of associated joint arthropathies. The cellular pathology of ochronosis in AKU mice is identical to that observed in early human ochronosis and thus is a model in which the early stages of joint pathology can be studied and novel interventions evaluated.


Assuntos
Cicloexanonas/farmacologia , Inibidores Enzimáticos/farmacologia , Artropatias/tratamento farmacológico , Artropatias/fisiopatologia , Nitrobenzoatos/farmacologia , Ocronose/tratamento farmacológico , Ocronose/fisiopatologia , 4-Hidroxifenilpiruvato Dioxigenase/antagonistas & inibidores , 4-Hidroxifenilpiruvato Dioxigenase/sangue , 4-Hidroxifenilpiruvato Dioxigenase/genética , Alcaptonúria , Animais , Condrócitos/efeitos dos fármacos , Condrócitos/patologia , Modelos Animais de Doenças , Feminino , Humanos , Artropatias/genética , Articulação do Joelho/patologia , Articulação do Joelho/fisiopatologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Ocronose/genética
2.
JIMD Rep ; 24: 45-50, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25940034

RESUMO

Alkaptonuria (AKU) is an ultrarare autosomal recessive disorder resulting from a deficiency of homogentisate 1,2 dioxygenase (HGD), an enzyme involved in the catabolism of phenylalanine and tyrosine. Loss of HGD function prevents metabolism of homogentisic acid (HGA), leading to increased levels of plasma HGA and urinary excretion. Excess HGA becomes deposited in collagenous tissues and subsequently undergoes polymerisation, principally in the cartilages of loaded joints, in a process known as ochronosis. This results in an early-onset, devastating osteoarthropathy for which there is currently no effective treatment. We recently described the natural history of ochronosis in a murine model of AKU, demonstrating that deposition of ochronotic pigment begins very early in life and accumulates with age. Using this model, we were able to show that lifetime treatment with nitisinone, a potential therapy for AKU, was able to completely prevent deposition of ochronotic pigment. However, although nitisinone has been shown to inhibit ochronotic deposition, whether it can also facilitate removal of existing pigment has not yet been examined. We describe here that midlife administration of nitisinone to AKU mice arrests further deposition of ochronotic pigment in the tibiofemoral joint, but does not result in the clearance of existing pigment. We also demonstrate the dose-dependent response of plasma HGA to nitisinone, highlighting its efficacy for personalised medicine, where dosage can be tailored to the individual AKU patient.

3.
J Trauma Stress ; 15(5): 339-50, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12392221

RESUMO

This cross-national study examined preparation for and psychological functioning following Hurricane Georges in the U.S. Virgin Islands, Puerto Rico, Dominican Republic, and the United States. Four to five weeks after the storm made landfall, 697 college students (222 men, 476 women) completed a questionnaire assessing demographic characteristics, preparation, social support, resource loss, and symptoms associated with acute stress disorder. Location, resource loss (especially personal characteristic resources) and social support accounted for a significant portion of psychological distress variance. The findings support the conservation of resources stress theory (Hobfoll, 1989, 1998). Implications of the findings and future research directions are discussed.


Assuntos
Desastres , Transtornos de Estresse Pós-Traumáticos/psicologia , Doença Aguda , Adolescente , Adulto , Comparação Transcultural , República Dominicana/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Porto Rico/epidemiologia , Transtornos de Estresse Pós-Traumáticos/epidemiologia , Estados Unidos/epidemiologia , Ilhas Virgens Americanas/epidemiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa